Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer

被引：17
|
作者：
Xu, Jimmy P. [1 ]
Branson, Jeffrey D. [1 ]
Lawrence, Rae [2 ]
Cocklin, Simon [1 ]
机构：
[1] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Rooms 10302-10306,245 North 15th St, Philadelphia, PA 19102 USA
[2] Cresset, New Cambridge House,Bassingbourn Rd, Litlington SG8 0SS, Cambs, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 03期
关键词：
Computer-aided drug design; Field-based virtual screening; HIV-1 capsid protein; Antiviral; Surface plasmon resonance; N-TERMINAL DOMAIN; ACTIVITY-RELATIONSHIPS SAR; CRYSTAL-STRUCTURES; HUMAN CYCLOPHILIN; BINDING-SITE; CA PROTEIN; OPTIMIZATION; REPLICATION; DISCOVERY; DIMERIZATION;
D O I：
10.1016/j.bmcl.2015.12.087
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The HIV-1 CA protein is an attractive therapeutic target for the development of new antivirals. An inter-protomer pocket within the hexamer configuration of the CA, which is a binding site for key host dependency factors, is an especially appealing region for small molecule targeting. Using a field-based pharmacophore derived from an inhibitor known to interact with this region, coupled to biochemical and biological assessment, we have identified a new compound that inhibits HIV-1 infection and that targets the assembled CA hexamer. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：824 / 828
页数：5
相关论文
共 50 条
  • [41] Discovery of a small-molecule HIV-1 integrase inhibitor-binding site
    Al-Mawsawi, Laith Q.
    Fikkert, Valery
    Dayam, Raveendra
    Witvrouw, Myriarn
    Burke, Terrence R., Jr.
    Borchers, Christoph H.
    Neamati, Nouri
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) : 10080 - 10085
  • [42] Shielding the HIV-1 capsid
    Christopher Aiken
    Nature Microbiology, 2020, 5 : 12 - 13
  • [43] Shielding the HIV-1 capsid
    Aiken, Christopher
    NATURE MICROBIOLOGY, 2020, 5 (01) : 12 - 13
  • [44] Antiviral Properties of HIV-1 Capsid Inhibitor GSK878
    Wang, Chunfu
    Huang, Haichang
    Mallon, Kirsten
    Valera, Lourdes
    Parcella, Kyle
    Cockett, Mark I.
    Kadow, John F.
    Gillis, Eric P.
    Krystal, Mark
    Fridell, Robert A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (05)
  • [45] Characterizing the interactions between the HIV-1 capsid protein and small molecule ligands using native mass spectrometry
    Harvey, Sophie
    PROTEIN SCIENCE, 2024, 33 : 77 - 77
  • [46] Identification of a novel small-molecule inhibitor of the HIV-1 reverse transcriptase activity with a non-nucleoside mode of action
    Yu, Kyung-Lee
    Shin, Younghyun
    Kim, Dong-Eun
    Kim, Jeong-Ah
    Kang, Jeong-Eun
    Singh, Pooja
    Lee, Keun Woo
    Park, Chul Min
    Kwon, Hojin
    Kim, Sunwoo
    Bae, Songmee
    Yoon, Cheol-Hee
    VIROLOGY JOURNAL, 2025, 22 (01)
  • [47] Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis
    Marquez, Chantal L.
    Lau, Derrick
    Walsh, James
    Shah, Vaibhav
    McGuinness, Conall
    Wong, Andrew
    Aggarwal, Anupriya
    Parker, Michael W.
    Jacques, David A.
    Turville, Stuart
    Bocking, Till
    ELIFE, 2018, 7
  • [48] HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir
    Troyano-Hernaez, Paloma
    Reinosa, Roberto
    Holguin, Africa
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [49] IP6, PF74 affect HIV-1 capsid stability through modulation of hexamer-hexamer tilt angle preference
    Garza, Chris M.
    Holcomb, Matthew
    Santos-Martins, Diogo
    Torbett, Bruce E.
    Forli, Stefano
    BIOPHYSICAL JOURNAL, 2025, 124 (02) : 417 - 427
  • [50] Electrostatic repulsion regulates hiv-1 capsid hexamer plasticity and assembling capacities into core-like structures
    Sonia Brun
    Laurent Chaloin
    Bernard Gay
    Eric Bernard
    Christian Devaux
    Corinne Lionne
    Nathalie Chazal
    Laurence Briant
    Retrovirology, 6
12345